Medozil Capsule 21 mg+10 mg is a combination therapy containing Memantine 21 mg and Donepezil 10 mg, formulated for the management of moderate to severe Alzheimer’s disease. This dual-action capsule targets multiple pathways in the brain to help improve cognitive function, memory, and daily living activities in patients suffering from neurodegenerative disorders.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Anti-Alzheimer’s / NMDA Receptor Antagonist + Acetylcholinesterase Inhibitor
Medozil Capsule 21 mg+10 mg is indicated for:
Moderate to severe Alzheimer’s disease
Cognitive impairment associated with dementia
Memory loss and functional decline due to neurodegeneration
Medozil combines two complementary mechanisms to target Alzheimer’s disease:
Memantine – an NMDA receptor antagonist that regulates glutamate activity in the brain. Excessive glutamate stimulation can lead to neuronal damage. Memantine helps protect nerve cells and improve cognitive function.
Donepezil – an acetylcholinesterase inhibitor that increases acetylcholine levels in the brain, enhancing communication between neurons and improving memory and learning.
The combination of Memantine and Donepezil provides synergistic benefits, offering better cognitive and functional outcomes than monotherapy alone.
Recommended dosage: 1 capsule daily, preferably at the same time each day.
Capsules should be swallowed whole with water and can be taken with or without food.
Dose adjustments may be required in patients with renal or hepatic impairment; consult a physician.
Long-term therapy should be regularly evaluated for effectiveness and tolerability.
Common side effects may include:
Nausea, vomiting, diarrhea
Dizziness or headache
Fatigue or somnolence
Confusion or hallucinations in some cases
Muscle cramps or tremors
Less common but serious side effects:
Cardiac arrhythmias
Severe allergic reactions (rash, swelling, difficulty breathing)
Hypersensitivity to Memantine, Donepezil, or any component of the formulation
History of severe liver or kidney impairment (caution required)
Gastrointestinal bleeding or active peptic ulcer in predisposed patients (for Donepezil)
Use with caution in patients with heart conditions, seizure disorders, or urinary obstruction.
May cause dizziness or somnolence; avoid driving or operating heavy machinery if affected.
Regular monitoring of cognitive function and clinical status is recommended.
Safety in pregnancy and lactation has not been established; use only if potential benefit outweighs risk.
May interact with anticholinergic drugs, NMDA antagonists, or other medications affecting the central nervous system.
Caution when co-administered with drugs that prolong QT interval or affect renal clearance.
Store in a cool, dry place below 30°C
Keep away from light, moisture, and out of reach of children
Login Or Registerto submit your questions to seller
No none asked to seller yet